CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX – Get Free Report) saw a significant increase in short interest in March. As of March 31st, there was short interest totalling 300 shares, an increase of 200.0% from the March 15th total of 100 shares. Based on an average trading volume of 56,600 shares, the days-to-cover ratio is currently 0.0 […]
CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX – Get Free Report) was the target of a significant decrease in short interest during the month of August. As of August 31st, there was short interest totalling 100 shares, a decrease of 99.2% from the August 15th total of 12,100 shares. Based on an average daily volume of 493,800 shares, […]
CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX – Get Free Report) was the recipient of a large drop in short interest during the month of July. As of July 31st, there was short interest totalling 5,900 shares, a drop of 83.8% from the July 15th total of 36,400 shares. Based on an average daily trading volume, of 818,000 […]
CNBX Pharmaceuticals (OTCMKTS:CNBX – Free Report) is one of 362 publicly-traded companies in the “Biotechnology” industry, but how does it weigh in compared to its rivals? We will compare CNBX Pharmaceuticals to related companies based on the strength of its earnings, dividends, analyst recommendations, valuation, institutional ownership, risk and profitability. Institutional & Insider Ownership 98.2% […]
CNBX Pharmaceuticals (OTCMKTS:CNBX – Get Rating) is one of 352 publicly-traded companies in the “Biotechnology” industry, but how does it contrast to its competitors? We will compare CNBX Pharmaceuticals to similar businesses based on the strength of its analyst recommendations, profitability, earnings, risk, dividends, valuation and institutional ownership. Institutional and Insider Ownership 98.2% of CNBX […]